Visit the OrganiGram Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Organigram Announces May 21st as Inaugural Date of Trading on the Nasdaq Global Select Market
MONCTON, May 17, 2019 /CNW/ – Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that its common shares will commence trading on the Nasdaq Global Select Market under the symbol “OGI” on Tuesday May 21, 2019. Organigram’s common shares will continue to be listed and trade on the Toronto Venture Exchange (TSXV), also under the symbol “OGI”. The Company’s common shares will continue to trade on the OTCQX under the symbol “OGRMF” until market close on May 20, 2019.
In conjunction with this Nasdaq listing, Organigram’s common shares will become DWAC/FAST eligible for U.S. shareholders.
We are pleased to celebrate this significant company milestone. We are proud to have assembled a world-class team and facility that continues to deliver value to our shareholders. This listing will help us continue to demonstrate our commitment to dynamic growth.
Greg Engel, CEO, Organigram
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.
For fact-based information on Organigram, view the company’s sponsored Investor Dashboard.